IL13 and Increased total eosinophil count: Eosinophilia after dupilumab treatment46, increase in downstream activity of OX40 ligand49, inhibition of IL-13 and indirect decreased production of mucin in the goblet cells of the conjunctiva are also potential factors that affect conjunctivitis50.